CN103735641A - Medicine for treating bone fracture and preparation method thereof - Google Patents
Medicine for treating bone fracture and preparation method thereof Download PDFInfo
- Publication number
- CN103735641A CN103735641A CN201410014256.8A CN201410014256A CN103735641A CN 103735641 A CN103735641 A CN 103735641A CN 201410014256 A CN201410014256 A CN 201410014256A CN 103735641 A CN103735641 A CN 103735641A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- medicine
- orally
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of traditional Chinese medicines, and in particular relates to a medicine for treating bone fracture and a preparation method thereof. The medicine for treating bone fracture is an external ointment comprising the following components in parts by weight: 27-33 parts of rhizoma corydalis, 18-22 parts of ligusticum wallichii, 27-33 parts of Chinese angelica, 18-22 parts of red peony root, 27-33 parts of pseudo-ginseng, 13.5-16.5 parts of paris polyphylla, 13.5-16.5 parts of bone-joining elixir, 13.5-16.5 parts of polypetala dunn, 18-22 parts of teasel root, 27-33 parts of sargentgloryvine stem, and 13.5-16.5 parts of lycopodium clavatum. The medicine cannot cause great pains or sequelae to the body of a patient, and can be matched with manual reduction for treatment in practical application.
Description
Technical field
The present invention relates to the field of Chinese medicines, medicine of fracturing in particular to treatment and preparation method thereof.
Background technology
Fracture refers to the seriality fracture (fracture wholly or in part) of bone structure.Wherein the most serious situation is comminuted fracture, and sclerotin is fragmented into more than three, is called again t or y type fracture open fracture, and fracture end communicates with the external world.
At present, the method for the treatment of comminuted fracture mainly contains invasive surgery and medicine.Wherein, invasive surgery treatment meeting brings very big misery to patient's health, and very person can leave sequela; And medicine in correlation technique is due to treatment time long (generally reaching 1-2), thereby can make patient suffer for a long time slight illness.
Summary of the invention
The object of the present invention is to provide medicine for the treatment of fracture and preparation method thereof, to solve the above problems.
Provide in an embodiment of the present invention a kind of medicine for the treatment of fracture to comprise the externally used paste consisting of the following composition: by weight, Rhizoma Corydalis 27-33 part, Rhizoma Chuanxiong 18-22 part, Radix Angelicae Sinensis 27-33 part, Radix Paeoniae Rubra 18-22 part, Radix Notoginseng 27-33 part, Rhizoma Paridis 13.5-16.5 part, Cortex torricelliae tiliifoliae 13.5-16.5 part, ferrum rattan 13.5-16.5 part, Radix Dipsaci 18-22 part, the logical 27-33 part of blood, Herba Lycopodii 13.5-16.5 part.
Further, also comprise Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part.
Further, also comprise Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Scorpio 9-11 part, Fructus Kochiae 18-22 part.
Further, also comprise Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 9-11 part, Radix Aucklandiae 10.8-13.2 part, Rhizoma Atractylodis Macrocephalae 16.2-19.8 part.
Further, also comprise Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part.
Further, also comprise Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Poria 18-22 part.
The preparation method of the medicine of above-mentioned treatment fracture, comprises the following steps:
All compositions in externally used paste are clayed into power, obtain pulverous medical material;
Pulverous medical material is mixed, obtain the first mixture;
The first mixture is made to externally used paste.
Further, also comprise: prepare Orally-administered decoction; The formula of Orally-administered decoction is the one in following formula:
Formula one, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part;
Formula two, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Scorpio 9-11 part, Fructus Kochiae 18-22 part;
Formula three, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 9-11 part, Radix Aucklandiae 10.8-13.2 part, Rhizoma Atractylodis Macrocephalae 16.2-19.8 part;
Formula four, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part;
Formula five, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Poria 18-22 part;
The preparation method of described Orally-administered decoction comprises the following steps:
All compositions in formula are mixed, obtain the second mixture;
Described in decocting, the second mixture, obtains Orally-administered decoction.
The main part of the medicine of the treatment fracture of the above embodiment of the present invention is externally used paste, and this externally used paste is to utilize the principle of monarch that 11 kinds of Chinese crude drugs such as Rhizoma Corydalis are combined, and it can effect a radical cure fracture, especially comminuted fracture.In addition, prove through clinical trial, instant effect when this medicine is used for the treatment of comminuted fracture, treatment time are short, transference cure in this medicine of patient's application more than 30 day, the recovery from illness in 2 months of this medicine of application; And the medicine of above embodiment do not need to carry out invasive surgery, thereby can not bring very big misery or sequela to patient's health, can coordinate in actual applications manual reduction to treat.
The composition principle of the medicine of more than treatment fracture is: ferrum rattan, Cortex torricelliae tiliifoliae, Rhizoma Paridis and Radix Dipsaci are monarch drug.Ferrum rattan: promoting the circulation of blood, expelling wind and removing dampness, internal hemorrhage, traumatic injury, reunion of fractured tendons and bones.Cortex torricelliae tiliifoliae: blood circulation promoting and blood stasis dispelling, relieving rigidity of muscles and knitting bone.Rhizoma Paridis: heat-clearing and toxic substances removing, reducing swelling and alleviating pain, reunion of fractured tendons and bones.Radix Dipsaci: invigorating the liver and kidney, promoting the circulation of blood arteries and veins, reuniting the fractured tendons and bones.Radix Notoginseng, blood lead to and Herba Lycopodii is ministerial drug.Radix Notoginseng: removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation.Blood is logical: heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, the long bone of invigorating blood circulation, channels sootheing and network vessel quickening.Herba Lycopodii: expelling wind and removing dampness, the long bone of invigorating blood circulation, relaxing muscles and tendons and activating QI and blood in the collateral.Rhizoma Chuanxiong and Radix Paeoniae Rubra are adjuvant drug.Rhizoma Chuanxiong: blood-activating and qi-promoting, dispel the wind pain, traumatic injury.Radix Paeoniae Rubra: clearing away heat and cooling blood, stasis-dispelling and pain-killing.Rhizoma Corydalis and make medicine when being classified as.Rhizoma Corydalis: invigorate blood circulation, circulation of qi promoting, pain relieving.Radix Angelicae Sinensis: enrich blood invigorate blood circulation, alleviating pain and detumescence.
More than the curative mechanism of the medicine for the treatment of fracture is: the traditional Chinese medical science is thought the nourishing of growth needs QI and blood of muscles and bones, and blockage of main and collateral channels, stagnation of QI-blood muscles and bones mistake are supported, and fracture is difficult.The present invention utilizes the mechanism treatment fracture of blood circulation promoting and blood stasis dispelling, meridians dredging just, has the feature for the treatment of both the principal and secondary aspects of a disease.
The specific embodiment
Below by specific embodiment, the present invention is described in further detail.
Embodiment mono-
The medicine for the treatment of fracture comprises the externally used paste consisting of the following composition: by weight, and Rhizoma Corydalis 27-33 part, Rhizoma Chuanxiong 18-22 part, Radix Angelicae Sinensis 27-33 part, Radix Paeoniae Rubra 18-22 part, Radix Notoginseng 27-33 part, Rhizoma Paridis 13.5-16.5 part, Cortex torricelliae tiliifoliae 13.5-16.5 part, ferrum rattan 13.5-16.5 part, Radix Dipsaci 18-22 part, the logical 27-33 part of blood, Herba Lycopodii 13.5-16.5 part.
The medicine of more than treatment fracture is to utilize the principle of monarch that 11 kinds of Chinese crude drugs such as Rhizoma Corydalis are combined, and it can effect a radical cure fracture, especially comminuted fracture.In addition, prove through clinical trial, instant effect when this medicine is used for the treatment of comminuted fracture, treatment time are short, transference cure in this medicine of patient's application more than 30 day, the recovery from illness in 2 months of this medicine of application; And the medicine of above embodiment do not need to carry out invasive surgery, thereby can not bring very big misery or sequela to patient's health, can coordinate in actual applications manual reduction to treat.
The composition principle of the medicine of more than treatment fracture is: ferrum rattan, Cortex torricelliae tiliifoliae, Rhizoma Paridis and Radix Dipsaci are monarch drug.Ferrum rattan: promoting the circulation of blood, expelling wind and removing dampness, internal hemorrhage, traumatic injury, reunion of fractured tendons and bones.Cortex torricelliae tiliifoliae: blood circulation promoting and blood stasis dispelling, relieving rigidity of muscles and knitting bone.Rhizoma Paridis: heat-clearing and toxic substances removing, reducing swelling and alleviating pain, reunion of fractured tendons and bones.Radix Dipsaci: invigorating the liver and kidney, promoting the circulation of blood arteries and veins, reuniting the fractured tendons and bones.Radix Notoginseng, blood lead to and Herba Lycopodii is ministerial drug.Radix Notoginseng: removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation.Blood is logical: heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, the long bone of invigorating blood circulation, channels sootheing and network vessel quickening.Herba Lycopodii: expelling wind and removing dampness, the long bone of invigorating blood circulation, relaxing muscles and tendons and activating QI and blood in the collateral.Rhizoma Chuanxiong and Radix Paeoniae Rubra are adjuvant drug.Rhizoma Chuanxiong: blood-activating and qi-promoting, dispel the wind pain, traumatic injury.Radix Paeoniae Rubra: clearing away heat and cooling blood, stasis-dispelling and pain-killing.Rhizoma Corydalis and make medicine when being classified as.Rhizoma Corydalis: invigorate blood circulation, circulation of qi promoting, pain relieving.Radix Angelicae Sinensis: enrich blood invigorate blood circulation, alleviating pain and detumescence.
More than the curative mechanism of the medicine for the treatment of fracture is: the traditional Chinese medical science is thought the nourishing of growth needs QI and blood of muscles and bones, and blockage of main and collateral channels, stagnation of QI-blood muscles and bones mistake are supported, and fracture is difficult.The present invention utilizes the mechanism treatment fracture of blood circulation promoting and blood stasis dispelling, meridians dredging just, has the feature for the treatment of both the principal and secondary aspects of a disease.
In above medicine, partial elements adopts the medical material of the processing such as vinegar is fried, yellow wine is fried or process, and can strengthen drug effect, makes medicine bring into play curative effect more.For example, vinegar fries that Rhizoma Corydalis, yellow wine Rhizoma Chuanxiong (parched), yellow wine Radix Paeoniae Rubra (parched), yellow wine fry that Radix Notoginseng, vinegar are fried Rhizoma Paridis, process Cortex torricelliae tiliifoliae, process ferrum rattan, Radix Dipsaci Preparata, yellow wine fry that blood is logical, vinegar is fried Herba Lycopodii.
When the externally used paste in the medicine of more than treatment fracture coordinates Orally-administered decoction, curative effect is better, and through evidence, the medicine of cooperation Orally-administered decoction takes effect sooner, treatment time is shorter, according to clinical experience, the ratio of Orally-administered decoction and externally used paste is that every 3 secondary externally used pastes are joined 1 secondary Orally-administered decoction, certainly, in the middle of actual therapeutic, the amount ratio of Orally-administered decoction and externally used paste can be adjusted according to taking the circumstances into consideration.Wherein, Orally-administered decoction can adopt any one in following five kinds of formulas:
Formula one, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part.
Formula two, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Scorpio 9-11 part, Fructus Kochiae 18-22 part.
Formula three, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 9-11 part, Radix Aucklandiae 10.8-13.2 part, Rhizoma Atractylodis Macrocephalae 16.2-19.8 part.
Formula four, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part.
Formula five, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Poria 18-22 part.
In the medicine of above treatment fracture, the each composition in externally used paste or Orally-administered decoction can adopt any part within the scope of its umber, on the basis of this umber, can do and optimize, and obtains following examples two to six.
Embodiment bis-
The medicine for the treatment of fracture comprises externally used paste and Orally-administered decoction.
Externally used paste consists of the following composition: by weight, and 30 parts of Rhizoma Corydalis, 20 parts of Rhizoma Chuanxiongs, 30 parts of Radix Angelicae Sinensis, 20 parts of Radix Paeoniae Rubra, 30 parts of Radix Notoginseng, 15 parts of Rhizoma Paridis, 15 parts of Cortex torricelliae tiliifoliaes, 15 parts, ferrum rattan, 20 parts of Radix Dipsacis, logical 30 parts of blood, 15 parts of Herba Lycopodiis.
Orally-administered decoction consists of the following composition: by weight, and 12 parts, Semen Persicae, 9 parts, Flos Carthami, 15 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Chuanxiongs, 20 parts of Radix Angelicae Sinensis, 20 parts, Radix Rehmanniae Preparata, 30 parts, the Radix Rehmanniae, 18 parts of Radix Achyranthis Bidentataes, 6 parts, Radix Glycyrrhizae.
Embodiment tri-
The medicine for the treatment of fracture comprises externally used paste and Orally-administered decoction.
Externally used paste consists of the following composition: by weight, and 30 parts of Rhizoma Corydalis, 20 parts of Rhizoma Chuanxiongs, 30 parts of Radix Angelicae Sinensis, 20 parts of Radix Paeoniae Rubra, 30 parts of Radix Notoginseng, 15 parts of Rhizoma Paridis, 15 parts of Cortex torricelliae tiliifoliaes, 15 parts, ferrum rattan, 20 parts of Radix Dipsacis, logical 30 parts of blood, 15 parts of Herba Lycopodiis.
Orally-administered decoction consists of the following composition: by weight, and 12 parts, Semen Persicae, 9 parts, Flos Carthami, 15 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Chuanxiongs, 20 parts of Radix Angelicae Sinensis, 20 parts, Radix Rehmanniae Preparata, 30 parts, the Radix Rehmanniae, 18 parts of Radix Achyranthis Bidentataes, 6 parts, Radix Glycyrrhizae, 12 parts of the Radix Aucklandiae, 10 parts of Scorpio, 20 parts of the Fructus Kochiae.
Embodiment tetra-
The medicine for the treatment of fracture comprises externally used paste and Orally-administered decoction.
Externally used paste consists of the following composition: by weight, and 30 parts of Rhizoma Corydalis, 20 parts of Rhizoma Chuanxiongs, 30 parts of Radix Angelicae Sinensis, 20 parts of Radix Paeoniae Rubra, 30 parts of Radix Notoginseng, 15 parts of Rhizoma Paridis, 15 parts of Cortex torricelliae tiliifoliaes, 15 parts, ferrum rattan, 20 parts of Radix Dipsacis, logical 30 parts of blood, 15 parts of Herba Lycopodiis.
Orally-administered decoction consists of the following composition: by weight, and 12 parts, Semen Persicae, 9 parts, Flos Carthami, 15 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Chuanxiongs, 20 parts of Radix Angelicae Sinensis, 20 parts, Radix Rehmanniae Preparata, 30 parts, the Radix Rehmanniae, 18 parts of Radix Achyranthis Bidentataes, 10 parts, Radix Glycyrrhizae, 12 parts of the Radix Aucklandiae, 18 parts of the Rhizoma Atractylodis Macrocephalaes.
Embodiment five
The medicine for the treatment of fracture comprises externally used paste and Orally-administered decoction.
Externally used paste consists of the following composition: by weight, and 30 parts of Rhizoma Corydalis, 20 parts of Rhizoma Chuanxiongs, 30 parts of Radix Angelicae Sinensis, 20 parts of Radix Paeoniae Rubra, 30 parts of Radix Notoginseng, 15 parts of Rhizoma Paridis, 15 parts of Cortex torricelliae tiliifoliaes, 15 parts, ferrum rattan, 20 parts of Radix Dipsacis, logical 30 parts of blood, 15 parts of Herba Lycopodiis.
Orally-administered decoction consists of the following composition: by weight, and 12 parts, Semen Persicae, 9 parts, Flos Carthami, 15 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Chuanxiongs, 20 parts of Radix Angelicae Sinensis, 20 parts, Radix Rehmanniae Preparata, 30 parts, the Radix Rehmanniae, 18 parts of Radix Achyranthis Bidentataes, 6 parts, Radix Glycyrrhizae, 12 parts of the Radix Aucklandiae.
Embodiment six
The medicine for the treatment of fracture comprises externally used paste and Orally-administered decoction.
Externally used paste consists of the following composition: by weight, and 30 parts of Rhizoma Corydalis, 20 parts of Rhizoma Chuanxiongs, 30 parts of Radix Angelicae Sinensis, 20 parts of Radix Paeoniae Rubra, 30 parts of Radix Notoginseng, 15 parts of Rhizoma Paridis, 15 parts of Cortex torricelliae tiliifoliaes, 15 parts, ferrum rattan, 20 parts of Radix Dipsacis, logical 30 parts of blood, 15 parts of Herba Lycopodiis.
Orally-administered decoction consists of the following composition: by weight, and 12 parts, Semen Persicae, 9 parts, Flos Carthami, 15 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Chuanxiongs, 20 parts of Radix Angelicae Sinensis, 20 parts, Radix Rehmanniae Preparata, 30 parts, the Radix Rehmanniae, 18 parts of Radix Achyranthis Bidentataes, 6 parts, Radix Glycyrrhizae, 12 parts of the Radix Aucklandiae, 20 parts of Poria.
Embodiment bis-to six can reach the technique effect of embodiment mono-, and without invasive surgery, instant effect, treatment time are short.In addition, the preferred version of embodiment mono-, and in the Orally-administered decoction of embodiment bis-to six, partial elements adopts the medical material of the processing such as vinegar is fried, yellow wine is fried or process, and can strengthen drug effect, makes medicine bring into play curative effect more.For example, yellow wine Semen Persicae (parched), yellow wine Radix Paeoniae Rubra (parched), vinegar Rhizoma Chuanxiong (parched), vinegar Radix Angelicae Sinensis (parched), yellow wine are fried Radix Achyranthis Bidentatae, Radix Glycyrrhizae Preparata, Rhizoma Atractylodis Macrocephalae (parched).
Embodiment seven
The present embodiment provides the preparation method of the medicine of embodiment mono-, comprises the following steps:
The first step: all compositions in externally used paste are clayed into power, obtain pulverous medical material.
Second step: pulverous medical material is mixed, obtain the first mixture.
The 3rd step: the first mixture is made to unguentum.
Above method is applicable to only have the medicine of external applied plaster agent, when medicine also comprises Orally-administered decoction, also needs to prepare Orally-administered decoction again, and the preparation method of Orally-administered decoction is: all compositions in Orally-administered decoction formula are mixed, obtain the second mixture; Decocting the second mixture, obtains Orally-administered decoction.Wherein, the condition optimization of decocting is: cold water is decocted low baking temperature stewing and opened about 10min, to guarantee that in medicine, active ingredient is not destroyed.The suggestion instructions of taking of Orally-administered decoction is: three times on the one, and each 200-300mL.The suggestion consumption of externally used paste is each 100g left and right (can adjust as one sees fit according to the state of an illness).
In addition, above in related preparation method, the method for making unguentum has a variety of, preferably adopts the storage time that following methods can prolong drug, and concrete grammar is: in the corn flour cooking, add distillers yeast, then sealing places 24-48h, obtain Semen Maydis cream; Again by weight, 1 part of Semen Maydis cream and 3.8-4.2 part the second mixture are mixed, obtain unguentum.In addition, through evidence, the time of guaranteeing the quality of the unguentum that employing the method makes is 6-12 month.While preparing Orally-administered decoction, in the time of by Semen Maydis cream and the mixing of the second mixture, also add: 0.8-0.9 part Chinese liquor, the mobility of increase unguentum.
In order to be illustrated more clearly in effect of the present invention, below also provide clinical example.
Clinical example one
Zheng, man, 36 years old, Binchuan County, Dali people from Zhoucheng, on January 16th, 2007, right ulnar fracture, is used medicine of the present invention detumescence silt after a week, within 21 days, carries out synthetism, and activity in 35 days freely, is fully recovered for 41 days.
Clinical example two
Huang, man, 22 years old, the blue or green Chinese of Dali Wei Shanxian, on February 4th, 2003, left tibia comminuted fracture, is used medicine of the present invention can walk after 38 days, recovery from illness in 51 days.
Clinical example three
Cai, man, 39 years old, the green small stream people in Nan Jian county, on August 3rd, 2006, right rib 678 fracture, cough with asthma at that time, all hurt like hells of walking about a little, are used medicine of the present invention symptom elimination after 15 days, recovery from illness in 43 days.
Clinical example four
Model, female, 64 years old, people from Suining City, Sichuan, on JIUYUE 2nd, 2013, sheet numbers 37069.Check finding and inspection record: cervical curvature straightens and instead bends, and cervical vertebra 5-6 vertebral body edge is shown in lip shape hyperosteogeny shadow, remaining vertebral body and each adnexa form, normal in size, each intervertebral space no abnormality seen.Lumbar vertebra is lateral bending left, each vertebral body form, structural integrity, and L1-5 anterior margin of vertebral body hyperosteogeny, corresponding intervertebral space is without obviously narrowing, and remaining intervertebral space and canalis spinalis have no obvious stenosis, diminish, and appendix of vertebra sclerotin shows no obvious abnormalities.Diagnosis phenomenon: 1, cervical vertebra degeneration, 2, lumbar retrogression.Clinical symptoms: dizzy, headache, general aching, walk long distances increases the weight of, and uses transference cure after medicine of the present invention January, recovery from illness in 45 days.
Clinical example five
Wang, female, 30 years old, people from Puer City, on JIUYUE 23rd, 2013.Check finding and inspection record: cervical vertebra four-bit slice, cervical curvature slightly straightens, neck 3-5 vertebral body top edges are slightly lip sample and change, lower edge comes to a point, cervical vertebral space, intervertebral foramina still can, ligamentum nuchae has no calcification.Diagnosis impression: hyperosteogeny that cervical vertebra is slight.Clinical symptoms: dizzy, headache, singultus, uncomfortable above the waist, use one week rear transference cure of medicine of the present invention, recovery from illness in 24 days.
Clinical example six
Hu, female, 59 years old, Bin Ju people from town, Binchuan County, on January 13rd, 2013.Check suggestion: 1, T11,12, L1,2,3,4,5 hyperosteogenys, vertebra waist section lateral bending distortion (intervertebral disc degeneration).2, the slight hyperosteogeny of the ultrawhite upper limb of right side hip.Clinical symptoms: thoracic vertebra, lumbar vertebra hyperosteogeny, the two lower limb of intervertebral disc degeneration compressing, are used two weeks rear transference cures of medicine of the present invention, recovery from illness in February.
Clinical example seven
Lee, man, 36 years old, Bin Ju people from town, Binchuan County, on June 5th, 2013.Image finding: CT is unenhanced for C3-7 intervertebral disc, C3-4 intervertebral disc is outstanding backward, and dural sac is pressurized slightly, and C4-5 intervertebral disc is outstanding backward, and dural sac is pressurized slightly, and it is obviously outstanding that C5-6 intervertebral disc has no, the slightly bulging of C6-7 intervertebral disc, dural sac is pressurized slightly.The aspect hyperosteogeny of cervical vertebra of sweeping.Impression: 1, C3-C7 intervertebral disc disorder is described above.2, sweep aspect hyperosteogeny of cervical vertebra.Clinical symptoms: dizzy, headache, vomiting, fuzzy viewing, both hands are dumb.After using medicine of the present invention January, symptom disappears completely, recovery from illness in February.
Clinical example eight
Cai, female, 39 years old, the Yi nationality, distributed over Yunnan, Sichuan and Guizhou, Xin Hu people from village, Bi Xi township, Dali prefecture Nan Jian county, going to the field on May 23rd, 2013 to plant is caused left humerus stage casing comminuted fracture by cattle top, large be broken into three sections and be completely connected, also have broken little osteocomma, too fat to move three times than usual of muscle, use medicine of the present invention after 9 days the too fat to move recovery of muscle normal.By 21 days, diagnose by observing signs on a patient's palm and hold up position, feel has synthetism, unlike feel is at that time snakelike, walked, to 32 days fingers can be movable, by 48 days, recover normal, after maintained 9 days.
Clinical example nine
Tea, female, 77 years old, check result: left hand anterioposterior and lateral film, left humerus hypomere comminuted fracture.After using separately externally used paste of the present invention to treat January, symptom disappears completely, recovery from illness in February.After using separately externally used paste of the present invention to treat January, symptom disappears completely, recovery from illness in February.
Clinical example ten
Yao, female, 59 years old, check result: left hand middle finger anterioposterior and lateral film, left hand middle finger epimere fracture.After using separately externally used paste of the present invention to treat January, symptom disappears completely, recovery from illness in February.
Clinical example 11
Wang, man, 17 years old, check result: left tibia and fibula anterioposterior and lateral film, left tibia hypomere sclerotin succession is interrupted, the overlapping displacement of disconnected section, all the other no abnormality seens.After using separately externally used paste of the present invention to treat January, symptom disappears completely, recovery from illness in February.
Clinical example 12
Wang, female, 59 years old, check result: l spine ap & lat sheet, lumbar vertebra physiological bending exists, vertebral body marshalling, L2,3,4,5 vertebral rim are lip sample and change, and intervertebral space is not wide, appendix of vertebra no abnormality seen.After using separately externally used paste of the present invention to treat January, symptom disappears completely, recovery from illness in February.
Clinical example 13
Poplar, man, 44 years old, clinical diagnosis: left foot injury.Check point: tibiofibula: left positive side position.Image finding: left tibia and fibula anterioposterior and lateral film, Fib L epimere sclerotin seriality is interrupted, and the displacement of fractured ends is not obvious, and remaining sclerotin is normal, and joint space is clear.Result: Fib L epimere fracture.After using separately externally used paste of the present invention to treat January, symptom disappears completely, recovery from illness in February.
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, for a person skilled in the art, the present invention can have various modifications and variations.Within the spirit and principles in the present invention all, any modification of doing, be equal to replacement, improvement etc., within all should being included in protection scope of the present invention.
Claims (8)
1. the medicine for the treatment of fracture, is characterized in that, comprises the externally used paste consisting of the following composition:
By weight, Rhizoma Corydalis 27-33 part, Rhizoma Chuanxiong 18-22 part, Radix Angelicae Sinensis 27-33 part, Radix Paeoniae Rubra 18-22 part, Radix Notoginseng 27-33 part, Rhizoma Paridis 13.5-16.5 part, Cortex torricelliae tiliifoliae 13.5-16.5 part, ferrum rattan 13.5-16.5 part, Radix Dipsaci 18-22 part, the logical 27-33 part of blood, Herba Lycopodii 13.5-16.5 part.
2. the medicine for the treatment of fracture according to claim 1, is characterized in that, also comprises Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part.
3. the medicine for the treatment of fracture according to claim 1, is characterized in that, also comprises Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Scorpio 9-11 part, Fructus Kochiae 18-22 part.
4. the medicine for the treatment of fracture according to claim 1, is characterized in that, also comprises Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 9-11 part, Radix Aucklandiae 10.8-13.2 part, Rhizoma Atractylodis Macrocephalae 16.2-19.8 part.
5. the medicine for the treatment of fracture according to claim 1, is characterized in that, also comprises Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part.
6. the medicine for the treatment of fracture according to claim 1, is characterized in that, also comprises Orally-administered decoction; Described Orally-administered decoction consists of the following composition:
By weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Poria 18-22 part.
7. the preparation method of the medicine for the treatment of fracture claimed in claim 1, is characterized in that, comprises the following steps:
All compositions in described externally used paste are clayed into power, obtain pulverous medical material;
Described pulverous medical material is mixed, obtain the first mixture;
Described the first mixture is made to externally used paste.
8. the preparation method of the medicine for the treatment of fracture according to claim 7, is characterized in that, also comprises: prepare Orally-administered decoction; The formula of described Orally-administered decoction is the one in following formula:
Formula one, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part;
Formula two, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Scorpio 9-11 part, Fructus Kochiae 18-22 part;
Formula three, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 9-11 part, Radix Aucklandiae 10.8-13.2 part, Rhizoma Atractylodis Macrocephalae 16.2-19.8 part;
Formula four, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part;
Formula five, by weight, Semen Persicae 10.8-13.2 part, Flos Carthami 8.1-9.9 part, Radix Paeoniae Rubra 13.5-16.5 part, Rhizoma Chuanxiong 13.5-16.5 part, Radix Angelicae Sinensis 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Rehmanniae 27-33 part, Radix Achyranthis Bidentatae 16.2-19.8 part, Radix Glycyrrhizae 5.4-6.6 part, Radix Aucklandiae 10.8-13.2 part, Poria 18-22 part;
The preparation method of described Orally-administered decoction comprises the following steps:
All compositions in formula are mixed, obtain the second mixture;
Described in decocting, the second mixture, obtains Orally-administered decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410014256.8A CN103735641B (en) | 2014-01-13 | 2014-01-13 | Medicine for the treatment of fracture and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410014256.8A CN103735641B (en) | 2014-01-13 | 2014-01-13 | Medicine for the treatment of fracture and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103735641A true CN103735641A (en) | 2014-04-23 |
| CN103735641B CN103735641B (en) | 2016-08-17 |
Family
ID=50492756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410014256.8A Active CN103735641B (en) | 2014-01-13 | 2014-01-13 | Medicine for the treatment of fracture and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103735641B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103961513A (en) * | 2014-06-02 | 2014-08-06 | 刘洪英 | Traditional Chinese medicine preparation for fracture nursing and preparation method thereof |
| CN104306537A (en) * | 2014-09-28 | 2015-01-28 | 刘虎 | Traditional Chinese medicine and ointment for treating bone fracture and osteonecrosis |
| CN104971140A (en) * | 2015-07-24 | 2015-10-14 | 青岛蓝盛洋医药生物科技有限责任公司 | Medicine composition for treating bone fracture and preparation method thereof |
| CN105267292A (en) * | 2015-09-30 | 2016-01-27 | 叶宗耀 | Pharmaceutical composition for treating bone fracture and preparation method of pharmaceutical composition for treating bone fracture |
| CN105497454A (en) * | 2015-12-19 | 2016-04-20 | 莫泽庸 | Medicine for treating fractures and preparation method thereof |
| CN107260912A (en) * | 2017-08-11 | 2017-10-20 | 曾德东 | It is a kind of to treat liniment of fracture and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1435189A (en) * | 2002-01-29 | 2003-08-13 | 金林海 | Ointment for treating fracture and injury |
| CA2385271A1 (en) * | 2002-05-22 | 2003-11-22 | Chen Wang | The powder for the root-cultivation, elimination of disaster and longevity |
| CN1634289A (en) * | 2004-10-22 | 2005-07-06 | 卜成武 | Ointment capable of expelling wind and eliminating stasis |
| CN101703692A (en) * | 2009-11-05 | 2010-05-12 | 卢速江 | Chinese medicinal preparation for treating bone fracture and preparation method thereof |
| CN102379941A (en) * | 2011-11-17 | 2012-03-21 | 中国中医科学院中医临床基础医学研究所 | Chinese medicinal compound preparation for treating fracture and preparation method thereof |
-
2014
- 2014-01-13 CN CN201410014256.8A patent/CN103735641B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1435189A (en) * | 2002-01-29 | 2003-08-13 | 金林海 | Ointment for treating fracture and injury |
| CA2385271A1 (en) * | 2002-05-22 | 2003-11-22 | Chen Wang | The powder for the root-cultivation, elimination of disaster and longevity |
| CN1634289A (en) * | 2004-10-22 | 2005-07-06 | 卜成武 | Ointment capable of expelling wind and eliminating stasis |
| CN101703692A (en) * | 2009-11-05 | 2010-05-12 | 卢速江 | Chinese medicinal preparation for treating bone fracture and preparation method thereof |
| CN102379941A (en) * | 2011-11-17 | 2012-03-21 | 中国中医科学院中医临床基础医学研究所 | Chinese medicinal compound preparation for treating fracture and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 《云南中草药整理组》: "《云南中草药》", 30 September 2011, 云南人民出版社 * |
| 赵金亮等: "折断式加压螺钉内固定配合中药治疗股骨颈骨折35例小结", 《湖南中医药导报》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103961513A (en) * | 2014-06-02 | 2014-08-06 | 刘洪英 | Traditional Chinese medicine preparation for fracture nursing and preparation method thereof |
| CN104306537A (en) * | 2014-09-28 | 2015-01-28 | 刘虎 | Traditional Chinese medicine and ointment for treating bone fracture and osteonecrosis |
| CN104971140A (en) * | 2015-07-24 | 2015-10-14 | 青岛蓝盛洋医药生物科技有限责任公司 | Medicine composition for treating bone fracture and preparation method thereof |
| CN105267292A (en) * | 2015-09-30 | 2016-01-27 | 叶宗耀 | Pharmaceutical composition for treating bone fracture and preparation method of pharmaceutical composition for treating bone fracture |
| CN105497454A (en) * | 2015-12-19 | 2016-04-20 | 莫泽庸 | Medicine for treating fractures and preparation method thereof |
| CN107260912A (en) * | 2017-08-11 | 2017-10-20 | 曾德东 | It is a kind of to treat liniment of fracture and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103735641B (en) | 2016-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103735641B (en) | Medicine for the treatment of fracture and preparation method thereof | |
| CN103735791B (en) | A kind of Chinese medicine composition and preparation method thereof for the treatment of lumbar vertebra, bone diseases | |
| CN104225508A (en) | Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof | |
| CN101112537A (en) | Chinese traditional medicine preparations for treating hyperosteogeny disease | |
| CN103861033A (en) | Formula of treating protrusion of lumbar intervertebral disc | |
| CN103550380A (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN106265999A (en) | A kind of treat cervical spondylosis, the pill medicine of lumbar spondylosis and preparation method | |
| CN106344894A (en) | Pill drug for treating cervical spondylosis and osteoarticular diseases and preparation method thereof | |
| CN103908511B (en) | One treats chondromatous Chinese medicinal pill and preparation method | |
| CN104435195A (en) | Orally-taken medicine for treating cervical spondylosis and preparation method thereof | |
| CN103735958B (en) | Medicine for the treatment of osteoproliferation, spur, disc herniation and preparation method thereof | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN105250966A (en) | Foot bath medicine for treatment of yang deficiency and preparation method and application thereof | |
| CN105663913A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
| CN104257851B (en) | A kind of Chinese medicine composition for the treatment of kidney deficiency blood stasis type femur head necrosis | |
| CN104306689B (en) | Traditional Chinese medicine composition for treating phlegm-dampness and collateral-obstruction type femoral head necrosis | |
| CN103656309B (en) | A kind of fracture/bone splits healing ancillary drug compositions | |
| CN102600396A (en) | Traditional Chinese medicinal preparation for treating common nerve compression in lumbar vertebral column cavity caused by hyperostosis | |
| CN106166275A (en) | A kind of decoction medicine treating chronic cervical syndrome and preparation method thereof | |
| CN106924673A (en) | A kind of Chinese medicine composition for treating osteoproliferation and its medicament preparation method | |
| CN104840758A (en) | Traditional Chinese medicine composition for treating dysmenorrheal and preparation method of traditional Chinese medicine composition | |
| CN104173963A (en) | Traditional Chinese medicinal composition for treating spleen-stomach yang-deficiency cold type infertility and application thereof | |
| CN104257953B (en) | The Chinese medicine composition for the treatment of wind cold wetness type femur head necrosis | |
| CN105983090A (en) | Pills for treating femoral head necrosis | |
| CN104383165A (en) | Foot bath traditional Chinese medicine powder capable of dispelling wind and relieving pain and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |